Safety of adjunctive intracoronary thrombolytic therapy during complex percutaneous coronary intervention: initial experience with intracoronary tenecteplase.
Kelly RV, Crouch E, Krumnacher H, Cohen MG, Stouffer GA.
Catheter Cardiovasc Interv. 2005 Nov;66(3):327-32. doi: 10.1002/ccd.20521.
Efficacy and safety of intracoronary pro-urokinase injection during percutaneous coronary intervention in treating ST elevation myocardial infarction patients: a systematic review and meta-analysis of randomized controlled trials.
Yin XS, Huang YW, Li ZP, Dong JL, Zou JM, Tian L, Yang J.
Eur Rev Med Pharmacol Sci. 2022 Aug;26(16):5802-5813. doi: 10.26355/eurrev_202208_29518.
Intracoronary injection of tirofiban prevents microcirculation dysfunction during delayed percutaneous coronary intervention in patients with acute myocardial infarction.
Sun Z, Zeng J, Huang H.
Int J Cardiol. 2016 Apr 1;208:137-40. doi: 10.1016/j.ijcard.2016.01.204. Epub 2016 Jan 23.
The influence of intracoronary injection of bone marrow cells on prothrombotic markers in patients with acute myocardial infarction.
Solheim S, Seljeflot I, Lunde K, Bratseth V, Aakhus S, Forfang K, Arnesen H.
Thromb Res. 2012 Nov;130(5):765-8. doi: 10.1016/j.thromres.2011.11.045. Epub 2011 Dec 20.
Myocardial imaging with thallium-201 for assessment of regional myocardial perfusion and viability after intracoronary thrombolytic therapy.
Beller GA.
Circulation. 1983 Aug;68(2 Pt 2):I70-6.
Intracoronary compared with intravenous bolus abciximab application in patients with ST-elevation myocardial infarction undergoing primary percutaneous coronary intervention: the randomized Leipzig immediate percutaneous coronary intervention abciximab IV versus IC in ST-elevation myocardial infarction trial.
Thiele H, Schindler K, Friedenberger J, Eitel I, Fürnau G, Grebe E, Erbs S, Linke A, Möbius-Winkler S, Kivelitz D, Schuler G.
Circulation. 2008 Jul 1;118(1):49-57. doi: 10.1161/CIRCULATIONAHA.107.747642. Epub 2008 Jun 16.
Kounis syndrome with Samter-Beer triad treated with intracoronary adrenaline.
Ihdayhid AR, Rankin J.
Catheter Cardiovasc Interv. 2015 Nov 15;86(6):E263-7. doi: 10.1002/ccd.25960. Epub 2015 Aug 10.
Intracoronary arterial retrograde thrombolysis with percutaneous coronary intervention: a novel use of thrombolytic to treat acute ST-segment elevation myocardial infarction.
Tian JW, Zhu M, Wang FQ, Li K, Zhou CF, Li B, Wang M, Deng JL, Jiang B, Bai J, Guo Y, Jin RJ, Zhang Z, Lin Y, Wang JH, Zhao SH, Shen MZ.
J Geriatr Cardiol. 2019 Jun;16(6):458-467. doi: 10.11909/j.issn.1671-5411.2019.06.004.
Effects of intracoronary injection of mononuclear bone marrow cells on left ventricular function, arrhythmia risk profile, and restenosis after thrombolytic therapy of acute myocardial infarction.
Huikuri HV, Kervinen K, Niemelä M, Ylitalo K, Säily M, Koistinen P, Savolainen ER, Ukkonen H, Pietilä M, Airaksinen JK, Knuuti J, Mäkikallio TH; FINCELL Investigators.
Eur Heart J. 2008 Nov;29(22):2723-32. doi: 10.1093/eurheartj/ehn436. Epub 2008 Oct 9.
Myocardial salvage after intracoronary thrombolysis with streptokinase in acute myocardial infarction.
Markis JE, Malagold M, Parker JA, Silverman KJ, Barry WH, Als AV, Paulin S, Grossman W, Braunwald E.
N Engl J Med. 1981 Oct 1;305(14):777-82. doi: 10.1056/NEJM198110013051401.
